Location History:
- Monza (Milan), IT (1976 - 1977)
- Monza, IT (1981 - 2017)
Company Filing History:
Years Active: 1976-2017
Title: The Innovative Contributions of Paolo Senin
Introduction
Paolo Senin is a notable inventor based in Monza, Italy, recognized for his significant contributions to the field of pharmaceuticals. With a total of 11 patents to his name, Senin has made strides in developing formulations that have beneficial effects on health, particularly concerning the cardiovascular system.
Latest Patents
Senin's latest patents include a formulation for oral administration that aims to improve cardiovascular health. This formulation, available in the form of tablets or powder for extemporaneous use, is designed to exert beneficial effects such as eulipidaemic activity, cholesterol-lowering, triglyceride-lowering, and antioxidant activity. It also provides protective action on the vasal endothelium, incorporating berberine in combination with policosanol and/or red yeast, and preferably containing antioxidants like astaxanthin and/or folic acid. Another significant patent is the crystalline and stable form of Andolast disodium salt, known as Form A. This new crystalline form displays a thermal event at 98-112°C and melts with decomposition at about 400°C. Notably, Andolast disodium Form A is a non-hygroscopic solid, demonstrating remarkable stability under various humidity conditions, which enhances both chemical and pharmaceutical manufacturing processes.
Career Highlights
Throughout his career, Paolo Senin has worked with reputable companies such as Rotta Research Laboratorium S.p.a. and Rottapharm Spa. His work in these organizations has contributed to advancements in pharmaceutical formulations and drug stability.
Collaborations
Senin has collaborated with esteemed colleagues, including Francesco Makovec and Luigi A Rovati, further enriching his research and development efforts in the pharmaceutical industry.
Conclusion
Paolo Senin's innovative work and numerous patents reflect his dedication to improving health outcomes through pharmaceutical advancements. His contributions continue to influence the field and pave the way for future innovations.